Call Options

32 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $21.6 Million - $25.4 Million
40,700 Added 3391.67%
41,900 $25.9 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $595,672 - $658,922
1,100 Added 1100.0%
1,200 $663,000
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $141 Million - $160 Million
-266,700 Reduced 99.96%
100 $58,000
Q4 2023

Feb 14, 2024

BUY
$431.41 - $532.94 $31.3 Million - $38.6 Million
72,500 Added 37.31%
266,800 $142 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $28.9 Million - $33.3 Million
57,900 Added 42.45%
194,300 $98.3 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $23.9 Million - $27.8 Million
-47,100 Reduced 25.67%
136,400 $71.2 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $223 Million - $252 Million
-416,600 Reduced 69.42%
183,500 $106 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $93.2 Million - $110 Million
192,200 Added 47.12%
600,100 $331 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $37.1 Million - $44.2 Million
-73,200 Reduced 15.22%
407,900 $207 Million
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $202 Million - $247 Million
404,200 Added 525.62%
481,100 $261 Million
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $40.3 Million - $49.6 Million
76,900 New
76,900 $45.4 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $78 Million - $91.4 Million
-137,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $33.1 Million - $38.8 Million
-58,200 Reduced 29.82%
137,000 $91.4 Million
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $99.5 Million - $119 Million
195,200 New
195,200 $112 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $67.9 Million - $81.2 Million
-133,200 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $58.7 Million - $67.7 Million
133,200 New
133,200 $67.2 Million
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $61.8 Million - $72.9 Million
-140,600 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $27 Million - $31.9 Million
61,400 Added 77.53%
140,600 $64.2 Million
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $34.5 Million - $41.8 Million
79,200 New
79,200 $36.9 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $81.6 Million - $98.9 Million
-187,500 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $39.9 Million - $48.9 Million
-110,800 Reduced 37.14%
187,500 $82.8 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $55.3 Million - $72.9 Million
201,100 Added 206.89%
298,300 $108 Million
Q1 2020

May 15, 2020

BUY
$255.3 - $340.05 $24.7 Million - $32.9 Million
96,800 Added 24200.0%
97,200 $27.6 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $3.15 Million - $3.81 Million
-11,600 Reduced 96.67%
400 $130,000
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $1.05 Million - $1.19 Million
3,900 Added 48.15%
12,000 $3.5 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $10.6 Million - $12.1 Million
-41,100 Reduced 83.54%
8,100 $2.38 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $85.1 Million - $110 Million
-401,100 Reduced 89.07%
49,200 $13.5 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $69.8 Million - $84.3 Million
334,700 Added 289.53%
450,300 $101 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $12 Million - $14.3 Million
-58,600 Reduced 33.64%
115,600 $28.2 Million
Q2 2018

Aug 14, 2018

BUY
$203.14 - $219.53 $12.5 Million - $13.5 Million
61,700 Added 54.84%
174,200 $36.1 Million
Q1 2018

May 15, 2018

BUY
$192.98 - $224.11 $19.7 Million - $22.9 Million
102,200 Added 992.23%
112,500 $23.2 Million
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $1.77 Million - $2 Million
10,300
10,300 $1.95 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $224B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.